NCT04667715View on ClinicalTrials.gov

Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 23, 2024

Primary Completion Date

October 23, 2024

Study Completion Date

October 23, 2024

Conditions
Glioma
Interventions
DEVICE

Exablate BBBD

Blood brain barrier disruption using ExAblate Type 2 device using microbubble resonators

Trial Locations (2)

21201

University of Maryland, Baltimore

77030

The University of Texas MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY